31 Dec 2018substantial holder notice● Neutral
Thanh Hoang disclosed a new substantial Bio-AMD Inc. shareholding (6.06% of votes).
Announcements, explained
Each one in plain English, with the numbers worked through for a shareholder.
6 Feb 2017material agreement● Neutral
On January 31, 2017 Bio-AMD again amended the MIDS Medical Limited agreement, moving the remaining Phase 1 Payments to $130,000 by March 15, $152,500 by April 15 and $75,000 by May 15, 2017; the $650,000 total is unchanged. The filing says MML has a surplus of development cash and no immediate need for more funding, filed a patent application on January 18, 2017 for a new 'Magnetic Bridge' detection method, and can draw payments early on 14 days' notice.
9 Dec 2016material agreement● Neutral
On December 6, 2016 Bio-AMD amended its agreement (dated June 20, 2016, amended September 29, 2016) for its joint venture MIDS Medical Limited, whose partner is to pay MML $650,000 in total in 'Phase 1 Payments'. Because extra design and testing work outside the original plan is under way and some planned work was deferred, the remaining payments were pushed back: $22,500 within 10 days, $152,500 by Jan 31, $130,000 by 'February 31' (as written in the filing) and $75,000 by March 31, 2017. The total stays at $650,000. This is a new venture after the Sysmex path ended in April 2016; the filing does not name the partner.
15 Nov 2016late filing notice▼ Bad
Bio-AMD Inc. notified the SEC that its quarterly report would be filed late.
14 Nov 2016quarterly activities report▼ Bad
Bio-AMD Inc. reported a quarterly net loss of $68 thousand for the period ended 2016-09-30.
15 Aug 2016quarterly activities report● Neutral
Bio-AMD Inc. reported a quarterly net income of $145 thousand for the period ended 2016-06-30.
23 May 2016quarterly activities report▼ Bad
Bio-AMD Inc. reported a quarterly net loss of $153 thousand for the period ended 2016-03-31.
17 May 2016late filing notice▼ Bad
Bio-AMD Inc. notified the SEC that its quarterly report would be filed late.
22 Apr 2016auditor change● Neutral
On April 20, 2016 Bio-AMD dismissed its auditor RBSM LLP, which it had used since 2009, and hired Saturna Group Chartered Professional Accountants LLP of Vancouver. The filing says the board made the change to reduce costs; RBSM reported no disagreements, and its reports for 2014 and 2015 carried going-concern doubt.
14 Apr 2016resource reserve update▼ BadMajor
On April 12, 2016 Sysmex told Bio-AMD Ltd. by phone that it would not proceed with the study, despite earlier calls on April 8 and 11 describing it as a top priority; the company says it believes the study was successfully completed and is awaiting written confirmation. This ends the Sysmex path from December 2014. The company says it will now try to find another partner for its COAG technology, citing earlier expressions of interest from more than one party, with no assurance of success.
15 Dec 2015substantial holder notice● Neutral
Benjamin L. Padnos disclosed a new substantial Bio-AMD Inc. shareholding (2.24% of votes).
9 Nov 2015quarterly activities report▼ Bad
Bio-AMD Inc. reported quarterly revenue of $0 and a net loss of $82 thousand for the period ended 2015-09-30.
13 Aug 2015quarterly activities report▼ Bad
Bio-AMD Inc. reported quarterly revenue of $0 and a net loss of $354 thousand for the period ended 2015-06-30.
14 May 2015quarterly activities report▼ Bad
Bio-AMD Inc. reported quarterly revenue of $0 and a net loss of $223 thousand for the period ended 2015-03-31.
19 Dec 2014material agreement▲ GoodMajor
On December 17, 2014 the majority-owned subsidiary Bio Alternative Medical Devices Ltd. signed a Master Agreement with Sysmex Corporation to jointly run a feasibility study of a point-of-care reader with test strips for PT-INR (blood clotting) tests. Sysmex will own the intellectual property and reimburse costs, with an advance of £642,067 (about $1,000,000) on signing; the agreement runs up to 27 months. The filing says there is no assurance that a manufacturing or license agreement or commercial sales will follow.
14 Nov 2014quarterly activities report▼ Bad
Bio-AMD Inc. reported quarterly revenue of $0 and a net loss of $306 thousand for the period ended 2014-09-30.
13 Aug 2014quarterly activities report▼ Bad
Bio-AMD Inc. reported quarterly revenue of $0 and a net loss of $242 thousand for the period ended 2014-06-30.
12 May 2014quarterly activities report▼ Bad
Bio-AMD Inc. reported quarterly revenue of $0 and a net loss of $316 thousand for the period ended 2014-03-31.
8 Nov 2013quarterly activities report▼ Bad
Bio-AMD Inc. reported quarterly revenue of $0 and a net loss of $265 thousand for the period ended 2013-09-30.
2 Aug 2013quarterly activities report▼ Bad
Bio-AMD Inc. reported quarterly revenue of $0 and a net loss of $271 thousand for the period ended 2013-06-30.
13 May 2013quarterly activities report● Neutral
Bio-AMD Inc. reported quarterly revenue of $0 for the period ended 2013-03-31.
13 May 2013quarterly activities report● Neutral
Bio-AMD Inc. reported quarterly revenue of $0 for the period ended 2013-03-31.
8 Nov 2012quarterly activities report● Neutral
Bio-AMD Inc. reported quarterly revenue of $0 for the period ended 2012-09-30.
2 Aug 2012quarterly activities report● Neutral
Bio-AMD Inc. reported quarterly revenue of $0 for the period ended 2012-06-30.
14 May 2012quarterly activities report● Neutral
Bio-AMD Inc. reported quarterly revenue of $0 for the period ended 2012-03-31.
9 Nov 2011quarterly activities report● Neutral
Bio-AMD Inc. reported quarterly revenue of $0 for the period ended 2011-09-30.
11 Aug 2011quarterly activities report● Neutral
Bio-AMD Inc. reported quarterly revenue of $0 for the period ended 2011-06-30.
12 May 2011quarterly activities report● Neutral
Bio-AMD Inc. reported quarterly revenue of $0 for the period ended 2011-03-31.
20 Apr 2011business combination● Neutral
On April 15, 2011 the company changed its name from Flex Fuels Energy, Inc. to Bio-AMD, Inc. through a merger with a newly formed wholly owned subsidiary, done solely to effect the name change. Shareholders become shareholders of the renamed company, and the stated reason is to reflect its core business area. The ticker 'FXFL' stays until FINRA assigns a new one.
1 Mar 2011substantial holder notice● Neutral
Thomas Barr disclosed a new substantial Bio-AMD Inc. shareholding (6.48% of votes).